H 1240
An Act relative to insulin access
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill, H.1240, addresses the high cost of insulin and aims to improve access for Massachusetts residents. It seeks to establish a process for reviewing and potentially regulating insulin prices, ensuring affordability for those who rely on the medication. The bill also intends to create a system for distributing free insulin to individuals who meet specific financial hardship criteria. Ultimately, the goal is to make insulin more accessible and prevent individuals from facing financial barriers to necessary healthcare.
Sponsors
Official sponsors from legislative records.
Primary sponsor
David Henry Argosky LeBoeuf
Cosponsors
Brian W. Murray
David Henry Argosky LeBoeuf
Kelly W. Pease
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill H.1240 194th (Current)
An Act relative to insulin access
By Representatives LeBoeuf of Worcester and Sabadosa of Northampton, a petition (accompanied by bill, House, No. 1240) of David Henry Argosky LeBoeuf and Lindsay N. Sabadosa relative to insulin access. Financial Services.
View Text Print Preview Download PDF
Bill Information
Bill Information
Presenters: David Henry Argosky LeBoeuf , Lindsay N. Sabadosa
Tabs
Bill History Petitioners Committee Summary Hearing Attendance
Bill History
Displaying 8 actions for Bill H.1240
| Date | Branch | Action |
| 2/27/2025 | House | Referred to the committee on Financial Services |
| 2/27/2025 | Senate | Senate concurred |
| 9/19/2025 | Joint | Hearing scheduled for 10/01/2025 from 10:30 AM-01:00 PM in B-2 |
| 9/25/2025 | Joint | Hearing rescheduled to 10/01/2025 from 10:30 AM-01:00 PM in A-1 and Virtual Hearing location changed |
| 9/29/2025 | Joint | Hearing rescheduled to 10/01/2025 from 10:30 AM-01:00 PM in B-1 and Virtual Hearing location changed |
| 10/1/2025 | Joint | Hearing rescheduled to 10/01/2025 from 10:30 AM-11:20 PM in B-1 and Virtual Hearing updated to New End Time |
| 10/1/2025 | Joint | Hearing scheduled for 10/01/2025 from 10:30 AM-01:00 PM in B-1 |
| 1/28/2026 | House | Accompanied a new draft, see H4950 |
Similar Bills
H.4950 194th (Current)
An Act relative to insulin access
H.4034 192nd (2021 - 2022)
An Act relative to insulin access
H.1212 194th (Current)
An Act relative to emergency insulin access
H.4944 194th (Current)
An Act relative to emergency insulin access
H.1132 192nd (2021 - 2022)
An Act relative to emergency insulin access
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.